Yhdysvallat - englanti - NLM (National Library of Medicine)

tula life llc - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - sunscreen • helps prevent sunburn. • if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Yhdysvallat - englanti - NLM (National Library of Medicine)

zo skin health, inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) -

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol hemihydrate 3.92mg equivalent to estradiol 3.79 mg (50 µg/24h) - transdermal patch - 50 mcg/24h - active: estradiol hemihydrate 3.92mg equivalent to estradiol 3.79 mg (50 µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - estradiol 0.312 mg/cm² equivalent to 50 µg/24h;   - transdermal patch - 50 mcg/24h - active: estradiol 0.312 mg/cm² equivalent to 50 µg/24h   excipient: ethyl acetate ethyl oleate glyceryl monolaurate isopropyl myristate methanol polyethylene

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - fluticasone propionate 8mg equivalent to 50 µg/dose;  ; salmeterol xinafoate 5.8mg equivalent to 25 µg/dose salmeterol;   - aerosol inhaler, metered dose - 50µg/25µg - active: fluticasone propionate 8mg equivalent to 50 µg/dose   salmeterol xinafoate 5.8mg equivalent to 25 µg/dose salmeterol   excipient: norflurane - seretide is indicated in the regular treatment of reversible obstructive airways disease (road), including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) is appropriate. this may include: patients on effective maintenance doses of long-acting ?-agonists and inhaled corticosteroids. patients who are symptomatic on current inhaled corticosteroid therapy. patients who are symptomatic on "as needed" short-acting betaagonists, as an alternative to initiation of maintenance therapy with moderate or high doses of inhaled corticosteroid alone.

Singapore - englanti - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins - injection, powder, for solution - 50 ld50 units - clostridium botulinum neurotoxin type a (150 kda), free from complexing proteins 50 ld50 units

Singapore - englanti - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - ciclosporin - injection - 50.0mg/ml - ciclosporin 50.0mg/ml

Singapore - englanti - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - clottable protein (human fibrinogen); human thrombin - solution - 50-90 mg/ml - clottable protein (human fibrinogen) 50-90 mg/ml; human thrombin 800-1200 iu/ml

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - lincomycin hydrochloride; spectinomycin sulfate tetrahydrate - solution for injection - 50, 100 milligram(s)/millilitre - lincomycin, combinations - cats, cattle, dogs, pigs - antibacterial

Australia - englanti - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; water for injections; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalamol 50/5 should not be used to initiate therapy.